About Austex Pharmaceutical Private Limited
Data last updated:
Austex Pharmaceutical Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2016PTC217765. Its GSTIN is 19AAOCA8311K1ZA (West Bengal). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors Sumit Kumar Singh and Shalini Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Howrah, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.27 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.5 Lakh (net margin 0.2%) and EBITDA of ₹26.4 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 36% over five years.
The company is associated with 1 brand: Austex. As per MCA filings, the company has open charges of ₹3.57 Cr on record. Court records list 9 cases involving the company, including 6 filed by the company and 3 filed against it; 5 cases are pending. The company has 4 deals on record (2 secondary share transfers, 2 rights issues); the latest was in July 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Scout Lifescience Private Limited with revenue of ₹12.41 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website austexpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address16 Dr. A N Pal Lane Jmt Enclave, Block – B Ground Floor, Howrah, West Bengal, India – 711201
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Austex Pharmaceutical Private Limited
Austex Pharmaceutical operates one associated brand: Austex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces and sells pharmaceutical products like antibiotics and multivitamins globally. | austexpharma.com |
Business Activity of Austex Pharmaceutical Private Limited
The main business activity of Austex Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Austex Pharmaceutical Private Limited FY 2025 filings available
Austex Pharmaceutical Private Limited reported revenue of ₹12.27 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Austex Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 12% growth in the latest year. EBITDA rose 470% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Austex Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.5 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Austex Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Austex Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Austex Pharmaceutical Private Limited
Austex Pharmaceutical has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Singh Also directs: Ausilabs Private Limited, Ausicare India Private Limited | Director | 27 Sep 2021 | 5 Years 0 Months | Current |
| Shalini Singh Also directs: Austex Agro Private Limited | Director | 18 Jul 2024 | 2 Years 3 Months | Current |
Peer Comparison of Austex Pharmaceutical Private Limited
Austex Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Scout Lifescience Private Limited | ₹12.41 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Naraingarh, Haryana, India |
| Avian Wellness Private Limited | ₹12.41 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Pune, Maharashtra, India |
| Jayanth Pharmaceuticals Private Limited | ₹12.36 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Hyderabad, Telangana, India |
| Repens Healthcare India Private Limited | ₹12.35 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bhayander, Maharashtra, India |
| Dermakare Pharmaceuticals Private Limited | ₹12.35 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Lucknow, Uttar Pradesh, India |
| Austex Pharmaceutical Private Limited this company | ₹12.27 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Howrah, West Bengal, India |
| Mtor Life Sciences Private Limited | ₹12.26 Cr (FY 2025) | •••• | •••• | 100.0% | •••• | New Delhi, Delhi, India |
| Omega Remedies Private Limited | ₹12.24 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Haryana, India |
| Parenteral Drugs (India) Limited Listed | ₹12.23 Cr (FY 2021) | •••• | •••• | -62.0% | •••• | Mumbai, Maharashtra, India |
| Aavkar Drugs Private Limited | ₹12.23 Cr (FY 2023) | •••• | •••• | -16.0% | •••• | Ankleshwar, Gujarat, India |
| Maximaa Systems Limited Listed | ₹12.2 Cr (FY 2019) | •••• | •••• | -2.0% | •••• | Valsad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Austex Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Austex Pharmaceutical Private Limited
Austex Pharmaceutical Private Limited is audited by P. K. SETHIA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P. K. SETHIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Austex Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Austex Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2025 | Others | ₹1.57 Cr | Open |
| 31 Aug 2024 | Indian Overseas Bank | ₹2 Cr | Open |
Total charge records: 2 View all charges
Deals & Funding of Austex Pharmaceutical Private Limited
Austex Pharmaceutical Private Limited has 4 deals on record (2 secondary share transfers, 2 rights issues); the latest was in July 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: JMT Investment Private Limited |
| Mar 2018 | Rights issue | ₹2 Lakh | Investors: an individual |
| Jan 2018 | Rights issue | ₹28 Lakh | Investors: JMT Investment Private Limited |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Austex Pharmaceutical Private Limited
Austex Pharmaceutical Private Limited has 9 court cases on record: 6 filed by Austex Pharmaceutical, 3 filed against it. 5 cases are pending and 4 are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 3 | 5 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Theon Pharmaceuticals Limited | Disposed |
| District court, Prayagraj, Uttar Pradesh | Criminal case | Filed against the company by State of U.P | Pending |
| District court, SURAT, Gujarat | Criminal complaint | Filed against the company by Tony Girishkumar Gandhi Autho Person of Globela Laboratories Pvt Ltd | Pending |
| District court, Howrah, West Bengal | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Austex Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Austex Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Austex Pharmaceutical Private Limited
Austex Pharmaceutical Private Limited has 8 board changes on record since 2016: 2 appointments and 6 cessations. The latest: Sumit Kumar Singh ceased to be Additional Director on 09 Aug 2024.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Austex Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Austex Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Austex Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Austex Pharmaceutical Private Limited
Austex Pharmaceutical has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAOCA8311K1ZA | West Bengal | Active | 30 Jul 2018 |
| 10AAOCA8311K1ZS | Bihar | Active | 16 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Austex Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Austex Pharmaceutical Private Limited
Austex Pharmaceutical is an active private limited company based in Howrah, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 September 2016 (10+ years old) and is registered under CIN U51909WB2016PTC217765.
Austex Pharmaceutical reported revenue of ₹12.27 Cr for FY 2025 (up 12% YoY).
Austex Pharmaceutical has 2 current directors:
- Sumit Kumar Singh - Director
- Shalini Singh - Director
Austex Pharmaceutical reported a net profit of ₹2.5 Lakh (net margin 0.2%) and EBITDA of ₹26.4 Lakh (EBITDA margin 2.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Austex Pharmaceutical is 30% over three years and 36% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Austex Pharmaceutical is 19AAOCA8311K1ZA, registered in West Bengal. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 10AAOCA8311K1ZS (Bihar).
The CIN (Corporate Identification Number) of Austex Pharmaceutical is U51909WB2016PTC217765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Austex Pharmaceutical has 9 court cases on record: 6 filed by the company and 3 filed against it. 5 are pending.
Austex Pharmaceutical was incorporated on 26 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Austex Pharmaceutical has 4 deals on record (2 secondary share transfers, 2 rights issues); the latest was in July 2018.
The peers of Austex Pharmaceutical by revenue are Scout Lifescience Private Limited, Avian Wellness Private Limited, Jayanth Pharmaceuticals Private Limited, Repens Healthcare India Private Limited, Dermakare Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).